Analyses Adjusting for Selective Crossover Show Improved Overall Survival With Adjuvant Letrozole Compared With Tamoxifen in the BIG 1-98 Study

Publisher's Note

The article by Colleoni et al, entitled, "Analyses Adjusting for Selective Crossover Show Improved Overall Survival With Adjuvant Letrozole Compared With Tamoxifen in the BIG 1-98 Study," (J Clin Oncol 10.1200/JCO.2010.31.6455) was published online February 14, 2011 with an error.

In the affiliations list, the Swiss Group for Clinical Cancer Research Statistical Center was given, whereas it should have been the International Breast Cancer Study Group Statistical Center.

This has been corrected as of February 28, 2011. Journal of Clinical Oncology apologizes to the authors and readers for the mistake.